IVIG IS OUR MIDDLE NAME Trademark

Trademark Overview


On Wednesday, April 3, 2019, a trademark application was filed for IVIG IS OUR MIDDLE NAME with the United States Patent and Trademark Office. The USPTO has given the IVIG IS OUR MIDDLE NAME trademark a serial number of 88368976. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 10, 2023. This trademark is owned by CSL Behring AG. The IVIG IS OUR MIDDLE NAME trademark is filed in the Paper & Printed Material Products, Advertising, Business and Retail Services, Education & Entertainment Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Healthcare education services, namely, conducting educational programs for patients, caregivers and/or healthcare professionals concerning immunoglobulin, immunodeficiency and neurological disorders, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals; planning and conducting educational conventions and educational meetings related to immunoglobulin, immunodeficiency and neurological disorders, their treatment and their impact on patients, patient families, caregivers and/or healthcare professionals

Printed materials, namely, newsletters, articles and case studies featuring immunoglobulin, immunodeficiency and neurological disorders; Printed publications, namely, brochures, booklets, newsletters, articles, case studies, and teaching materials in the field of immunoglobulin, immunodeficiency and neurological disorders; printed educational materials in the field of immunoglobulin, immunodeficiency and neurological disorders

Healthcare education services, namely, promoting awareness of immunoglobulin, immunodeficiency and neurological disorders, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals to patients, caregivers and/or healthcare professionals

Providing a website featuring information in the field of immunoglobulin, immunodeficiency and neurological disorders, and corresponding treatments; Healthcare and healthcare information services, namely, providing information concerning immunoglobulin, immunodeficiency and neurological disorders, their treatment and their impact on patients, patient families, caregivers and/or healthcare professionals; Healthcare and healthcare information services, namely, providing information concerning patient lifestyle and wellness for patients, caregivers, parents, teachers, coaches and friends impacted by immunoglobulin, immunodeficiency and neurological disorders; Providing a website featuring information in the field of the diagnosis and treatment of immunoglobulin, immunodeficiency and neurological disorders; Providing links to the web sites of others featuring information about the diagnosis and treatment of immunoglobulin, immunodeficiency and neurological disorders
ivig is our middle name

General Information


Serial Number88368976
Word MarkIVIG IS OUR MIDDLE NAME
Filing DateWednesday, April 3, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 10, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 14, 2020

Trademark Statements


Goods and ServicesHealthcare education services, namely, conducting educational programs for patients, caregivers and/or healthcare professionals concerning immunoglobulin, immunodeficiency and neurological disorders, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals; planning and conducting educational conventions and educational meetings related to immunoglobulin, immunodeficiency and neurological disorders, their treatment and their impact on patients, patient families, caregivers and/or healthcare professionals
Goods and ServicesPrinted materials, namely, newsletters, articles and case studies featuring immunoglobulin, immunodeficiency and neurological disorders; Printed publications, namely, brochures, booklets, newsletters, articles, case studies, and teaching materials in the field of immunoglobulin, immunodeficiency and neurological disorders; printed educational materials in the field of immunoglobulin, immunodeficiency and neurological disorders
Pseudo MarkINTRAVENOUS IMMUNOGLOBULIN IS OUR MIDDLE NAME
Goods and ServicesHealthcare education services, namely, promoting awareness of immunoglobulin, immunodeficiency and neurological disorders, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals to patients, caregivers and/or healthcare professionals
Goods and ServicesProviding a website featuring information in the field of immunoglobulin, immunodeficiency and neurological disorders, and corresponding treatments; Healthcare and healthcare information services, namely, providing information concerning immunoglobulin, immunodeficiency and neurological disorders, their treatment and their impact on patients, patient families, caregivers and/or healthcare professionals; Healthcare and healthcare information services, namely, providing information concerning patient lifestyle and wellness for patients, caregivers, parents, teachers, coaches and friends impacted by immunoglobulin, immunodeficiency and neurological disorders; Providing a website featuring information in the field of the diagnosis and treatment of immunoglobulin, immunodeficiency and neurological disorders; Providing links to the web sites of others featuring information about the diagnosis and treatment of immunoglobulin, immunodeficiency and neurological disorders
Disclaimer with Predetermined Text"IVIG"

Classification Information


International Class016 - Paper, cardboard and goods made from these materials, not included in other classes; printed matter; bookbinding material; photographs; stationery; adhesives for stationery or household purposes; artists' materials; paint brushes; typewriters and office requisites (except furniture); instructional and teaching material (except apparatus); plastic materials for packaging (not included in other classes); printers' type; printing blocks.
US Class Codes002, 005, 022, 023, 029, 037, 038, 050
Class Status Code6 - Active
Class Status DateSaturday, April 20, 2019
Primary Code016
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, December 9, 2019
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateSaturday, April 20, 2019
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, April 20, 2019
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCSL Behring AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressBern 3014
CH

Party NameCSL Behring AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressBern 3014
CH

Trademark Events


Event DateEvent Description
Monday, April 10, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 10, 2023ABANDONMENT - NO USE STATEMENT FILED
Saturday, August 20, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 19, 2022SOU EXTENSION 5 GRANTED
Wednesday, August 10, 2022SOU EXTENSION 5 FILED
Friday, August 19, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 10, 2022TEAS EXTENSION RECEIVED
Saturday, February 12, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 10, 2022SOU EXTENSION 4 GRANTED
Thursday, February 10, 2022SOU EXTENSION 4 FILED
Thursday, February 10, 2022TEAS EXTENSION RECEIVED
Thursday, August 12, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 10, 2021SOU EXTENSION 3 GRANTED
Tuesday, August 10, 2021SOU EXTENSION 3 FILED
Tuesday, August 10, 2021TEAS EXTENSION RECEIVED
Friday, February 12, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 10, 2021SOU EXTENSION 2 GRANTED
Wednesday, February 10, 2021SOU EXTENSION 2 FILED
Wednesday, February 10, 2021TEAS EXTENSION RECEIVED
Wednesday, August 12, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 10, 2020SOU EXTENSION 1 GRANTED
Monday, August 10, 2020SOU EXTENSION 1 FILED
Monday, August 10, 2020TEAS EXTENSION RECEIVED
Tuesday, March 10, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 14, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 14, 2020PUBLISHED FOR OPPOSITION
Wednesday, December 25, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 10, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 9, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 9, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 9, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 20, 2019NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Thursday, June 20, 2019EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Thursday, June 20, 2019COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Thursday, June 20, 2019EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Wednesday, June 12, 2019ASSIGNED TO EXAMINER
Saturday, April 20, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 6, 2019NEW APPLICATION ENTERED